9.255USD-5.27%Mkt Cap: 738.14M USDP/E: —Last update: 2026-06-01
Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III cli…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap738.14M USD
Enterprise Value1.13B USD
Revenue (TTM)204.89M USD
Gross Profit152.51M USD
Net Income (TTM)-221.25M USD
Revenue/Share2.716 USD
Last Price9.255 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees371
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)6.66
PEG—
EV/EBITDA-11.78
EV/Revenue5.52
P/S3.73
P/B-2.26
EPS (TTM)-2.09
EPS (Forward)1.44
52W Range
4.05037% of range18.31
52W High18.31 USD
52W Low4.050 USD
Profitability
Gross Margin87.09%
Oper. Margin-26.55%
EBITDA Margin-46.87%
Profit Margin-126.35%
ROE50.49%
ROA-85.37%
Growth
Revenue Growth104.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-166.78M USD
CapEx (TTM)229.00K USD
FCF Margin-37.84%
FCF Yield-10.50%
Net Debt366.31M USD
Net Debt/EBITDA-3.81
Balance Sheet
Debt/Equity-0.48
Current Ratio2.21
Quick Ratio2.09
Book Value/Sh-4.2420 USD
Cash/Share2.268 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)23.70 USD
Target Range13.00 USD – 29.00 USD
# Analysts10
Ownership
Shares Out.79.76M
Float60.43M
Insiders4.73%
Institutions88.44%
Short Interest
Short Ratio7.3d
Short % Float13.59%
Short % Out.12.90%
Shares Short10.29M
Short (prev mo.)9.50M
Technical
SMA 5011.76 (-21.3%)
SMA 20012.85 (-28.0%)
Beta0.57
S&P 52W Chg27.70%
Avg Vol (30d)1.29M
Avg Vol (10d)1.12M
Technical Indicators
RSI (14)31.3
MACD-0.3942
MACD Signal-0.1597
MACD Hist.-0.2345
BB Upper13.50 USD
BB Middle11.84 USD
BB Lower10.17 USD
BB Width28.14%
ATR (14)0.7529 USD
Vol Ratio (20d)0.69x